<DOC>
	<DOCNO>NCT00264303</DOCNO>
	<brief_summary>A study compare clinical efficacy safety Levocetirizine vs. Desloratadine patient suffer Chronic Idiopathic Urticaria ( CIU ) measure mean pruritus severity score first week treatment</brief_summary>
	<brief_title>CUTE ( Chronic Urticaria Treatment Evaluation )</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>At visit 1 : Clinical history Chronic Idiopathic Urticaria period least 6 week last 3 month without identifiable cause At visit 2 ( baseline period least 3 day ) : patient adequate sign CIU , term symptoms severity . Any condition would interfere evaluation therapeutic response .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Chronic Idiopathic Urticaria</keyword>
	<keyword>CUTE Levocetirizine XyzalÂ®</keyword>
</DOC>